Literature DB >> 9731846

Risk factors for familial and sporadic ovarian cancer among French Canadians: a case-control study.

B Godard1, W D Foulkes, D Provencher, J S Brunet, P N Tonin, A M Mes-Masson, S A Narod, P Ghadirian.   

Abstract

OBJECTIVE: The objective was to compare risk factors between familial and sporadic ovarian cancer by means of a case-control approach. STUDY
DESIGN: We conducted a case-control study among French Canadian women in Montreal during 1995-1996. One hundred seventy women 20 to 84 years old with histologically confirmed diagnoses of primary ovarian carcinomas or borderline tumors were interviewed concerning their reproductive, family, and medical histories. During the same period 170 randomly selected population control subjects, frequency-matched to the case patients according to age and ethnic group, were also interviewed. Unconditional logistic regression methods were used for data analysis.
RESULTS: The major factors influencing the risk of development of ovarian cancer were as follows: (1) family history of breast or ovarian cancer, (2) a late age at use of oral contraceptives (a protective effect), and (3) a late age at last childbirth (a protective effect for familial case patients only).
CONCLUSION: These factors had equally great impacts in familial and sporadic cases, implying that the underlying mechanisms of carcinogenesis in sporadic and familial ovarian cancer may be similar and that hereditary ovarian cancer may be preventable.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9731846     DOI: 10.1016/s0002-9378(98)70372-2

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  14 in total

1.  Ovarian cancer in Canada.

Authors:  B Moloughney; J Snider; L Villeneuve
Journal:  CMAJ       Date:  2000-03-07       Impact factor: 8.262

Review 2.  Forth nightly review: hereditary ovarian carcinoma.

Authors:  L Kasprzak; W D Foulkes; A N Shelling
Journal:  BMJ       Date:  1999-03-20

Review 3.  Hereditary ovarian cancer in Ashkenazi Jews.

Authors:  Luis Robles-Díaz; Deborah J Goldfrank; Noah D Kauff; Mark Robson; Kenneth Offit
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

Review 4.  Perineal talc use and ovarian cancer: a critical review.

Authors:  Joshua E Muscat; Michael S Huncharek
Journal:  Eur J Cancer Prev       Date:  2008-04       Impact factor: 2.497

5.  A review of histopathological subtypes of ovarian cancer in BRCA-related French Canadian cancer families.

Authors:  Patricia N Tonin; Christine M Maugard; Chantal Perret; Anne-Marie Mes-Masson; Diane M Provencher
Journal:  Fam Cancer       Date:  2007-07-17       Impact factor: 2.375

6.  NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer.

Authors:  Janice L Berliner; Angela Musial Fay; Shelly A Cummings; Brittany Burnett; Todd Tillmanns
Journal:  J Genet Couns       Date:  2012-11-28       Impact factor: 2.537

7.  Menstrual and reproductive factors in relation to ovarian cancer risk.

Authors:  L Titus-Ernstoff; K Perez; D W Cramer; B L Harlow; J A Baron; E R Greenberg
Journal:  Br J Cancer       Date:  2001-03-02       Impact factor: 7.640

8.  The effect of talc particles on phagocytes in co-culture with ovarian cancer cells.

Authors:  Angelo Mandarino; David J Gregory; Connor C McGuire; Brian W Leblanc; Hadley Witt; Loreilys Mejias Rivera; John J Godleski; Alexey V Fedulov
Journal:  Environ Res       Date:  2019-08-22       Impact factor: 6.498

9.  Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium.

Authors:  C L Pearce; A M Near; D J Van Den Berg; S J Ramus; A Gentry-Maharaj; U Menon; S A Gayther; A R Anderson; C K Edlund; A H Wu; X Chen; J Beesley; P M Webb; S K Holt; C Chen; J A Doherty; M A Rossing; A S Whittemore; V McGuire; R A DiCioccio; M T Goodman; G Lurie; M E Carney; L R Wilkens; R B Ness; K B Moysich; R Edwards; E Jennison; S K Kjaer; E Hogdall; C K Hogdall; E L Goode; T A Sellers; R A Vierkant; J M Cunningham; J C Cunningham; J M Schildkraut; A Berchuck; P G Moorman; E S Iversen; D W Cramer; K L Terry; A F Vitonis; L Titus-Ernstoff; H Song; P D P Pharoah; A B Spurdle; H Anton-Culver; A Ziogas; W Brewster; V Galitovskiy; G Chenevix-Trench
Journal:  Br J Cancer       Date:  2009-01-06       Impact factor: 7.640

10.  Other Gynecologic Cancers: endometrial, ovarian, vulvar and vaginal cancers.

Authors:  Eliane Duarte-Franco; Eduardo L Franco
Journal:  BMC Womens Health       Date:  2004-08-25       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.